Welcome to Oncotype DX®
Oncotype DX is a clinically validated laboratory test, ordered by authorized healthcare providers, that predicts the likelihood of breast cancer recurrence in women with newly diagnosed, early stage invasive breast cancer. Oncotype DX also assesses the benefit from chemotherapy. To learn more about Oncotype DX, choose from the options below.
|
